Panel Discussion | Second- and Third-Generation Aortic Valve Systems Not Yet Approved in the US

Tuesday, March 11, 2025

9:36 AM - 10:00 AM ET

Panel Moderator(s)

Kendra J. Grubb, MD

VP/CMO Structural Heart
Medtronic
Atlanta, Georgia, United States

Disclosure information not submitted.
Toby Rogers, MD, PhD

Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure information not submitted.

Panel Discussant(s)

Andreas Baumbach, MD, FRCP, FESC

Chair
Queen Mary University of London
London, England, United Kingdom

Disclosure(s): Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Meril Lifesciences: Consultant (Ongoing); Pi-Cardia: Consulting Fees (e.g., advisory boards) (Ongoing)
Bassem Chehab, MD

Director - Structural Heart Program
Ascension Via Christi
Wichita, Kansas, United States

No relationships to disclose
Danny Chu, MD

Professor of Cardiothoracic Surgery
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States

No relationships to disclose
Yair Feld, MD, PhD

Director -Interventional cardiology
Tzafon Medical Center (Poriya), Israel

No relationships to disclose
Eberhard Grube, MD, MSCAI

Head CIIC
University Hospital Bonn
Bonn, Nordrhein-Westfalen, Germany

Disclosure information not submitted.
Dean J. Kereiakes, MD, FACC, MSCAI

Chairman, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
The Christ Hospital Health Network
Cincinnati, Ohio, United States

No relationships to disclose
Duane Pinto, MD, MPH, FSCAI

Chief Medical Officer
JenaValve
Boston, Massachusetts, United States

Disclosure information not submitted.
Horst Sievert, MD, FSCAI, FACC, FESC

Director
CardioVascular Center Frankfurt CVC
Frankfurt, Hessen, Germany

No relationships to disclose
Mark A. Turco, MD

CEO & President
JC Medical and Genesis MedTech
Providence, Rhode Island, United States

No relationships to disclose
Pradeep Yadav, MD

Director of Structural Interventions
Piedmont Atlanta Hospital
Atlanta, Georgia, United States

Disclosure(s): Abbott Labs: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSCI: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); DASI Simulations: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Excision Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medtronic.: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing); Trisol: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Kendra J. Grubb, MD: Medtronic: Employee (Ongoing)

Toby Rogers, MD, PhD: Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)

Andreas Baumbach, MD, FRCP, FESC: Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Meril Lifesciences: Consultant (Ongoing); Pi-Cardia: Consulting Fees (e.g., advisory boards) (Ongoing)

Bassem Chehab, MD: No financial relationships to disclose

Danny Chu, MD: Sanamedi, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Proctor (Ongoing)

Yair Feld, MD, PhD: No financial relationships to disclose

Dean J. Kereiakes, MD, FACC, MSCAI: Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Elixir Medical Corporation: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); JC Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Orchestra Biomed: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Sino Medical Sciences Technology, Inc.: Consultant (Ongoing)

Duane Pinto, MD, MPH, FSCAI: AriaCV: Consultant (Ongoing); JenaValve Technology Inc: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Horst Sievert, MD, FSCAI, FACC, FESC: Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Bioventrix, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, K2, Laminar, Lifetech: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Magenta, Maquet Getinge Group, Metavention, Mitralix, Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria to institution, travel expenses, consulting fees (Ongoing)

Mark A. Turco, MD: No financial relationships to disclose

Pradeep Yadav, MD: Abbott Labs: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSCI: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); DASI Simulations: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Excision Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medtronic.: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing); Trisol: Consulting Fees (e.g., advisory boards) (Ongoing)